AVEO Oncology Message Board


What's the Strategy in the U.S. for Neovasc's Reducer?

8 months ago

Neovasc (Nasdaq: NVCN) is a medical device company primarily known for Reducer, which is a minimally invasive device that helps treat patients with refractory angina. The device has been approved in Europe

What's the Strategy in the U.S. for Neovasc's Reducer?

8 months ago

Neovasc (Nasdaq: NVCN) is a medical device company primarily known for Reducer, which is a minimally invasive device that helps treat patients with refractory angina. The device has been approved in Europe

AVEO Stock

10 months ago

A quote from Lucera:

“With a New Drug Application filing for tivozanib expected in the first quarter of 2020, I believe AVEO is well-positioned to deliver on its goal of bringing novel, effective cancer therapies to patients with high unmet need,” said Mr. Lucera. “I look forward to working alongside an accomplished leadership team and to contributing to the Company’s success.”

AVEO Oncology Jobs

11 months ago

AVEO is the equivelent of the walking dead.

Loading...